Cuzick, Jack
Article History
Received: 14 November 2017
Revised: 14 November 2017
Accepted: 26 January 2018
First Online: 23 April 2018
Conflict of interest
: The author’s institution has received funding or material without cost for research studies from AstraZeneca, Aventis Pharma, Myriad Genetics, Bayer, Qiagen, Beckton Dickinson, Hologic, Abbott, Genera Biosystems, Roche, Trovagene and Cepheid. J.C. has received honoraria or consulting fees from AstraZeneca, Myriad Genetics, Bayer, Roche, Qiagen, Becton Dickinson, Roche, Trovagene, Merck, Atossa Genetics and Cancer Prevention Pharmaceuticals.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International licence (CC BY 4.0).